Has Latin Billionaire Spotted Screaming Buy
Carlos Slim made a splash in a surprising sector last year, choosing to bet big on oil production and refining businesses.
Throughout 2024, the (in)famous investor deployed about $1 billion into the oil market, including a little over $600 million in US refining company PBF Energy (NYSE:PBF).
Why is it about this relatively obscure energy name that has attracted Carlos Slim, » Read more about: Has Latin Billionaire Spotted Screaming Buy »
Read More
Is This High Growth Stock Breaking Out?
Billionaire Stan Druckenmiller was once asked how he thinks about performance and his answer was quite insightful. Most traders might say something like “I aim to make 15% a year” or some other specific figure, but Stan’s answer was I like to “compare myself to the opportunity set” and beat it, meaning whatever the market is doing he likes to ensure he’s generating higher returns,
» Read more about: Is This High Growth Stock Breaking Out? »
Read More
Got $3,000? Here Are 3 Best Warren Buffett Stocks to Buy
Warren Buffett’s portfolio at Berkshire Hathaway has been an excellent source of ideas for generations of investors. Even though the Oracle of Omaha is pulling back to cash heavily this year, there are still some fantastic stocks being held at Berkshire that appear undervalued and bear watching.
Here are three of the best Buffett stocks to look into if you have a few thousand dollars to put to work in today’s market.
» Read more about: Got $3,000? Here Are 3 Best Warren Buffett Stocks to Buy »
Read More
Is This Insane 14.9% Dividend Yield Safe?
Dividends have historically been an extremely important factor in investors’ overall returns in the stock market, providing liquid income and creating opportunities for growth through reinvestment.
Today, though, soaring stock prices associated with expectations of high future growth have sent dividend yields well below their historical averages. The S&P 500 today yields just 1.2%,
» Read more about: Is This Insane 14.9% Dividend Yield Safe? »
Read More
Why On Earth Is Soros Buying Radio Stations?
Earlier this year, billionaire investor and political donor George Soros drew a great deal of attention for suddenly acquiring about 200 radio stations in 40 national market from Audacy, a legacy broadcasting network.
Unsurprisingly, Soros faced both regulatory hurdles and political backlash for buying up so many broadcast stations at once.
Why is George Soros buying radio stations,
» Read more about: Why On Earth Is Soros Buying Radio Stations? »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Spotlight
1 High Energy Drink To Buy on the Dip?
Celsius Holdings (NASDAQ:CELH) is the maker of a line of energy drinks that has skyrocketed in popularity in recent years.
Once virtually unknown, Celsius has used social media marketing and celebrity influencer deals to rapidly build its brand awareness.
Although the product itself has been quite successful, the stock’s performance hasn’t matched it.
» Read more about: 1 High Energy Drink To Buy on the Dip? »
Read MoreThe Daily
Trump Begins Selling New Crypto Token, Raising Ethical Concerns
President-elect Donald J. Trump and his family on Friday started selling a cryptocurrency token featuring an image of Mr. Trump drawn from the July assassination attempt, a potentially lucrative new business that ethics experts assailed as a blatant effort to cash in on the office he is about to occupy again.
» Read more about: Trump Begins Selling New Crypto Token, Raising Ethical Concerns »